How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?
- DOI
- 10.1016/j.therap.2025.10.010
- Published
- 2026-01
- Container
- Therapies
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.therap.2025.10.010,
title = {How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?},
author = {Clémentine Body and Frédéric Chassagnol and Driss Berdaï and Jean-François Bergmann and Isabelle Borget and Carole Doré and Alexandra Durr and Bruno Falissard and Joumana Hudry and Benjamin Kowalski and Philippe Maugendre and Nicolas Schlumberger and Elodie Wilmet and Claire Le Jeunne},
year = {2026},
journal = {Therapies},
doi = {10.1016/j.therap.2025.10.010},
url = {https://doi.org/10.1016/j.therap.2025.10.010}
}RIS
TY - JOUR TI - How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway? AU - Clémentine Body AU - Frédéric Chassagnol AU - Driss Berdaï AU - Jean-François Bergmann AU - Isabelle Borget AU - Carole Doré AU - Alexandra Durr AU - Bruno Falissard AU - Joumana Hudry AU - Benjamin Kowalski AU - Philippe Maugendre AU - Nicolas Schlumberger AU - Elodie Wilmet AU - Claire Le Jeunne PY - 2026 JO - Therapies DO - 10.1016/j.therap.2025.10.010 UR - https://doi.org/10.1016/j.therap.2025.10.010 ER -
APA
Body, C., Chassagnol, F., Berdaï, D., Bergmann, J., Borget, I., Doré, C., Durr, A., Falissard, B., Hudry, J., Kowalski, B., Maugendre, P., Schlumberger, N., Wilmet, E., & Jeunne, C. L. (2026). How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?. Therapies. https://doi.org/10.1016/j.therap.2025.10.010
Source records
- crossref · retrieved 2026-09-25T09:49:01.498Z